col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


155 Results       Page 1

 [1] 
Scientific and Technological Research Council of Turkey: TURKISH JOURNAL OF MEDICAL SCIENCES
  original article Date Title Authors   All Authors
1 [GO] 2024―Oct―23 Role of CT-based body composition parameters in the course of COVID-19 ELÇİN AYDIN, BEGÜM ERGİN, EZGİ GÜVEL VERDİ, ÖZGE COŞKUN, ŞÜKRÜ ŞAHİN, ALİ HAYDAR BAYKAN, HİLAL ŞAHİN
2 [GO] 2024―Oct―23 Evaluation with structural equation modeling of variables affecting health-seeking behaviors during the COVID-19 pandemic in İstanbul, Türkiye PINAR ATALI, SEYHAN HIDIROĞLU, ALİCAN SARISALTIK, MELDA KARAVUŞ
3 [GO] 2024―Sep―03 Relationship between functional status and fatigue after COVID-19 infection: a multicenter study from Türkiye İPEK CANDEMİR, PINAR ERGÜN, DİCLE KAYMAZ, MUSTAFA ENGİN ŞAHİN, İPEK ÖZMEN, ELİF YILDIRIM, et al. (+24)
4 [GO] 2024―Sep―03 Do patients infected with human coronavirus before the COVID-19 pandemic have less risk of being infected with COVID-19? GAMZE ŞANLIDAĞ İŞBİLEN, AYÇA AYDIN UYSAL, SELİN YİĞİT, ÖZGÜR APPAK, HİLAL SİPAHİ, GÜLENDAM BOZDAYI, et al. (+4)
5 [GO] 2024―Jun―18 Comparison of radiologic findings between SARS-CoV-2 and other respiratory tract viruses in critically ill children during the COVID-19 pandemic OKTAY PERK, TANIL KENDİRLİ, EMEL UYAR, BİRSEL ŞEN AKOVA, HATİCE ALBAYRAK, HASAN AĞIN, et al. (+14)
6 [GO] 2024―Feb―20 Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients Aslıhan Avanoğlu GÜLER, Büşra ÖZÇİMEN, Mesude Seda AYDOĞDU, Alper SARI, Aliyeva NUMUNE, Nazife Tüzün ERSAN, et al. (+15)
7 [GO] 2023―Dec―17 COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period GÜLŞEN İSKENDER, DUYGU MERT, GÖKNUR YAPAR TOROS, FUNDA YILMAZ, ERSİN BOZAN, SEMRA TUNÇBİLEK, et al. (+3)
8 [GO] 2023―Dec―17 Positive effects of health behaviors acquired during the COVID-19 pandemic process on the prevention of other infectious diseases ASİYE ÇİĞDEM ŞİMŞEK, TURAN BUZGAN, FATMA NUR BARAN AKSAKAL, ŞUAYIP BİRİNCİ, HÜLYA ŞİRİN
9 [GO] 2023―Oct―31 Alterations in B and NK cells highly correlate with disease severity in children with COVID-19 EZGİ TOPYILDIZ, NESLİHAN KARACA, RAZİYE BURCU TAŞKIN, AYŞE AYGÜN, ZÜMRÜT ŞAHBUDAK BAL, EYLEM ULAŞ SAZ, et al. (+3)
10 [GO] 2023―Oct―31 Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome EMRAH ŞENEL, SEYHAN TÜRK, ÜMİT YAVUZ MALKAN, MUSTAFA ÇAĞRI PEKER, CAN TÜRK, HATİCE RAHMET GÜNER, et al. (+9)
11 [GO] 2023―Oct―31 Which sequence should be used in the thorax magnetic resonance imaging of COVID-19: a comparative study AYŞE ŞULE ATEŞ, BURAK YAĞDIRAN, ONUR TAYDAŞ, ÖMER FARUK ATEŞ
12 [GO] 2023―Oct―31 Clinical and laboratory features in health care volunteers with inactivated SARS-CoV-2 vaccination ZHIJIE LI, YAFANG WAN, LANLAN XU, WENJIA ZHANG, YU ZHANG, PU LIAO
13 [GO] 2023―Feb―24 COVID-19 modeling based on real geographic and population data EMİR BAYSAZAN, AHMET NİHAT BERKER, HASAN MANDAL, HAKAN KAYGUSUZ
14 [GO] 2022―Dec―23 COVID-19 in pediatric nephrology centers in Turkey EMRE LEVENTOĞLU, YEŞİM ÖZDEMİR ATİKEL, HÜLYA NALÇACIOĞLU, İSMAİL DURSUN, HASAN DURSUN, ZEYNEP NAGEHAN YÜRÜK YILDIRIM, et al. (+9)
15 [GO] 2022―Dec―23 A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection MEVLÜT TAMER DİNCER, NECMİ EREN, AHMET MURT, NURİYE YILDIZ, ŞEYDA GÜL ÖZCAN, METİN ERGÜL, et al. (+6)
16 [GO] 2022―Dec―23 Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination SERKAN İŞGÖREN, GİZEM KÖROĞLU, GÖZDE DAĞLIÖZ GÖRÜR, HAKAN DEMİR
17 [GO] 2022―Oct―21 The effect of frailty on the development of acute kidney injury in critically-ill geriatric patients with COVID-19 MURAT KÜÇÜK, BİŞAR ERGÜN, MEHMET NURİ YAKAR, ÖZER URAL ÇAKICI, ERDEM YAKA, BİLGİN CÖMERT, et al. (+2)
18 [GO] 2022―Oct―21 Brain hypoxia caused by respiratory obstruction which should not be forgotten in COVID-19 disease ALEKSANDR URAKOV, NIKITA MUHUTDINOV, ILNUR YAGUDIN, DARYA SUNTSOVA, MILENA SVETOVA
19 [GO] 2022―Oct―21 Magnetic resonance imaging findings in COVID-19-related anosmia HÜSEYİN ÇETİN, AYŞE ŞULE ATEŞ, OGÜN TAYDAŞ, BAHRİ ELMAS, ERTUĞRUL GÜÇLÜ
20 [GO] 2022―Oct―21 Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study ORHAN KÜÇÜKŞAHİN, ABDULSAMET ERDEN, ÖZLEM KARAKAŞ, SERDAR CAN GÜVEN, BERKAN ARMAĞAN, ENES SEYDA ŞAHİNER, et al. (+9)
21 [GO] 2022―Aug―15 Remdesivir treatment for patients with moderate to severe COVID-19 İMRAN HASANOĞLU, HATİCE RAHMET GÜNER, İLHAMİ ÇELİK, FİKRET KANAT, AYŞE BATIREL, GÜLÇİN TELLİ DİZMAN, et al. (+9)
22 [GO] 2022―Aug―15 The role of CD8+ regulatory T cells and B cell subsets in patients with COVID-19 HÜLYA UÇARYILMAZ, DİLEK ERGÜN, HÜSAMETTİN VATANSEV, HANDE KÖKSAL, ONUR URAL, UĞUR ARSLAN, HASİBE ARTAÇ
23 [GO] 2022―Aug―15 COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature BERKAN ARMAĞAN, MEHMET AKİF EKSİN, SERDAR CAN GÜVEN, BAHAR ÖZDEMİR, PINAR AKYÜZ DAĞLI, ORHAN KÜÇÜKŞAHİN, et al. (+2)
24 [GO] 2022―Aug―15 Cross-sectional study of Middle East respiratory syndrome coronavirus in humans and dromedary camels in Diyala, Iraq ABDULRAZAK HASAN, KAREEM ALI, MOHAMMAD SALEH
25 [GO] 2022―Aug―15 Future pandemics: how can we be ready? ZEYNEP TÜRE YÜCE, EMİNE ALP MEŞE
26 [GO] 2022―Jul―08 Return visit characteristics of SARS-CoV-2 PCR-positive cases in a pediatric emergency department NİHAN ŞIK, DURGÜL ÖZDEMİR, MURAT DUMAN
27 [GO] 2022―Jul―08 Risk factors and prognosis in children hospitalized due to pandemic H1N1 influenza A virus infection in Ankara, Turkey* MEDİNE AYŞİN TAŞAR, YILDIZ BİLGE, ÖZGE UYSAL SOYER, ŞÜKRAN YILDIRIM, MUSTAFA TAŞAR, FATMA İNCİ ARIKAN
28 [GO] 2022―Jul―08 Chest radiography and computed tomography findings of cases with pandemic influenza A (H1N1/09) infection PINAR NERCİS KOŞAR, ZELİHA KOÇAK TUFAN, ELİF ERGÜN, HASAN YİĞİT, UĞUR KOŞAR, ALİ PEKCAN DEMİRÖZ
29 [GO] 2022―Jun―22 The clinical follow-up and management of COVID-19 in children and adolescents withan immunocompromised state or a malignancy İREM CEREN ERBAŞ, HATİCE KARAOĞLU ASRAK, AYŞE ÇAKIL GÜZİN, ŞİLEM ÖZDEM ALATAŞ, ŞEFİKA AKYOL, MERAL TORUN BAYRAM, et al. (+4)
30 [GO] 2022―Jun―22 Turkey's transition to face-to-face schooling during the COVID-19 pandemic MAHMUT ÖZER, HAYRİ EREN SUNA, MATJAZ PERC, SADRİ ŞENSOY, SEVİL UYGUN İLİKHAN
31 [GO] 2022―Jun―22 The effect of COVID-19 pandemic in a large series of patients with Takayasu arteritis ALİ KARAKAŞ, TUBA YÜCE İNEL, FATOŞ ÖNEN, İSMAİL SARI
32 [GO] 2022―Jun―22 Determination of COVID-19 PCR positivity and mutation status in coronaVacvaccinated individuals in Turkey AHMET ÇALIŞKAN, MÜCAHİT SEÇME, İLKNUR KALELİ, TUĞBA SARI, SEDEF ZELİHA ÖNER, SANİYE KÜÇÜKAKIN YAKA, BÜŞRA DÖNMEZ
33 [GO] 2022―Jun―22 An evaluation of the results of convalescent plasma therapy applied to pregnant womendiagnosed as COVID-19- positive in a pandemic center: A prospective cohort study SEYİT AHMET EROL, ATAKAN TANAÇAN, HAKAN APAYDIN, ŞULE GÖNCÜ AYHAN, DENİZ OLUKLU, DERYA UYAN HENDEM, et al. (+7)
34 [GO] 2022―Jun―22 The efficacy of anakinra compared to standard care of treatment for COVID-19: a metaanalysis HAMNA MALIK, HIRA BINT ABDUL JABBAR, FARAH LATIF, AZZA SARFRAZ, ZOUINA SARFRAZ, MUZNA SARFRAZ
35 [GO] 2022―May―19 Evaluation of the frequency and intensity of COVID-19 in patients with ankylosingspondylitis under anti-TNF therapy SÜMEYYE MERVE TÜRK, ZEYNEP ÖZTÜRK, DAMLA KARATAŞ, ÜNAL ERKORKMAZ, EMEL GÖNÜLLÜ
36 [GO] 2021―Dec―18 From asymptomatic to critical illness: decoding various clinical stages of COVID-19 İlhami ÇELİK, Recep ÖZTÜRK
37 [GO] 2021―Dec―18 Achievements of the COVID-19 Turkey Platform in vaccine and drug development with an approach of “co-creation and s쳮ding together” Hasan MANDAL
38 [GO] 2021―Nov―30 Immune dysfunction in COVID-19 and judicious use of anti-rheumatic drugs for the treatment of hyperinflammation
39 [GO] 2021―Nov―30 Epidemiology of COVID-19: What Changed in One Year?
40 [GO] 2021―Nov―12 EVALUATION OF THE FREQUENCY and INTENSITY OF COVID-19 IN PATIENTS WITH ANKYLOSING SPONDYLITIS UNDER ANTI-TNF THERAPY
41 [GO] 2021―Nov―12 Effect of Tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospecitve cohort study
42 [GO] 2021―Nov―04 Evaluation of Coagulation with TEG in Patients Diagnosed COVID-19
43 [GO] 2021―Oct―19 SARS-COV-2 vaccine: First-month results of a six-month follow-up study
44 [GO] 2021―Oct―06 Magnetic Resonance Imaging Findings in COVID-19-related Anosmia: Initial Results
45 [GO] 2021―Sep―30 Non-pharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic
46 [GO] 2021―Sep―30 COVID-19 and SEPSIS
47 [GO] 2021―Sep―19 Pregnancy and COVID-19: Prevention, Vaccination, Therapy and Beyond
48 [GO] 2021―Sep―08 A COVID-19 First Evaluation Clinic at a University Hospital in Turkey
49 [GO] 2021―Sep―08 Decrease of left ventricular ejection fraction in severe illness patients due to COVID-19 may improve as the disease resolves
50 [GO] 2021―Aug―29 Correlation of neuroimaging and thorax CT findings in patients with COVID-19: a large single-center experience
51 [GO] 2021―Aug―29 Clinical Characteristics and Risk Factors for 28-day Mortality in Critically Ill Patients with COVID-19: A Retrospective Cohort Study
52 [GO] 2021―Aug―27 From Asymptomatic to Critical Illness: Decoding Various Clinical Stages of COVID-19
53 [GO] 2021―Aug―21 Retrospective Evaluation of Seven Different Treatment Protocols in Hospitalized COVID-19 Patients
54 [GO] 2021―Aug―16 From asymptomatic to critical illness different clinical manifestations of COVID-19 in Children
55 [GO] 2021―Aug―16 Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients
56 [GO] 2021―Aug―15 Evaluating the efficiency of public policy measures against COVID-19
57 [GO] 2021―Aug―15 Antiviral treatment of COVID-19: An update
58 [GO] 2021―Aug―09 THE RADIOLOGICAL FINDINGS OF COVID-19
59 [GO] 2021―Aug―09 Short-Term Economic Impact of the Covid-19 Pandemic on the Global and Turkish Economy
60 [GO] 2021―Aug―09 Turkey?s Response to COVID-19 Pandemic: Strategy and Key Actions
61 [GO] 2021―Aug―09 RNA-Based COVID-19 Vaccine Candidates with Clinical Phase Trials in Progress
62 [GO] 2021―Aug―09 GLOBAL HEALTH EMERGENCIES DURING THE PANDEMIC AND THEIR SOLUTIONS
63 [GO] 2021―Aug―04 Comparison of SARS-COV2 antibody assays in PCR negative and PCR positive Turkish patients
64 [GO] 2021―Aug―02 Assessment of olfactory and gustatory functions in COVID-19 patients
65 [GO] 2021―Aug―02 Implementation of post-intensive care outpatient clinic (I-POINT) for critically-ill COVID-19 survivors
66 [GO] 2021―Aug―02 ALLERGIC REACTIONS AGAINST COVID-19 VACCINES
67 [GO] 2021―Jul―22 Current Infection Prevention and Control Strategies of COVID-19 in Hospitals
68 [GO] 2021―Jul―21 Managing life during the pandemic: Communication strategies, mental health and the ultimate toll of the COVID-19
69 [GO] 2021―Jul―21 One and a half years into the COVID-19 pandemic - Exit strategies and efficacy of SARS-CoV-2 vaccines for holistic management and achieving global control
70 [GO] 2021―Jul―21 How efficient are facial masks against COVID-19? Evaluating the mask use of various communities one year into the pandemic
71 [GO] 2021―Jul―21 Pandemic Hospitals and Re-organizing Emergency Departments
72 [GO] 2021―Jul―07 Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity
73 [GO] 2021―Jun―27 Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients
74 [GO] 2021―Jun―23 Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19
75 [GO] 2021―Jun―13 Effect of Coronavirus Pandemic on Organ Donation and Transplantation in Turkey
76 [GO] 2021―Jun―10 Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19
77 [GO] 2021―Jun―07 COVID-19 third wave: A challenge for overburdened and shabby healthcare system of Pakistan
78 [GO] 2021―May―23 Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis
79 [GO] 2021―May―19 Galectin-3: Can It Be A Diagnostic Tool For Pneumonia In COVID-19 Patients?
80 [GO] 2021―May―07 Covid-19 Clinical Course and Blood Groups: Turkish Population-Based Study
81 [GO] 2021―May―07 Risk Factors Associated with Mortality in Intensive Care COVID-19 Patients: the importance of chest CT score and intubation timing as risk factors
82 [GO] 2021―Apr―30 First known COVID-19 case and contact tracing efforts in Istanbul, Turkey
83 [GO] 2021―Apr―23 Pleural complications of Covid-19 pneumonia
84 [GO] 2021―Apr―21 Pulse Steroid Treatment for Hospitalized Adults with COVID-19
85 [GO] 2021―Apr―21 The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients
86 [GO] 2021―Apr―16 A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic
87 [GO] 2021―Apr―12 Impact of COVID-19 on serum melatonin levels and sleep parameters in children
88 [GO] 2021―Mar―28 Effects of the COVID-19 Pandemic on Psychology and Disease Activity in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis
89 [GO] 2021―Mar―17 Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?
90 [GO] 2021―Mar―15 The Comparison of Lopinavir/Ritonavir Combination and Favipiravir In COVID-19 Treatment
91 [GO] 2021―Mar―11 Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic
92 [GO] 2021―Mar―08 The Relationship of Extent of Initial Radiological Involvement with the Need of Intensive Care, Mortality Rates and Laboratory Parameters in COVID-19.
93 [GO] 2021―Mar―08 CURRENT COMMUNITY TRANSMISSION AND FUTURE PERSPECTIVES ON THE COVID-19 PROCESS
94 [GO] 2021―Mar―01 An evaluation of chest computed tomography and hemogram data in patients with COVID-19: The importance of the thymus
95 [GO] 2021―Feb―22 Impact of Hospital-acquired Acute Kidney Injury on Covid-19 Outcomes in Patients with and without Chronic Kidney Disease: A multicentre, retrospective cohort study
96 [GO] 2021―Feb―22 Preferences of Inflammatory Arthritis Patients for Biological Disease-Modifying Antirheumatic Drugs in the First 100 Days of COVID-19 Pandemic
97 [GO] 2021―Feb―14 SARS-CoV-2 associated rhabdomyolysis in 32 patients
98 [GO] 2021―Feb―01 How Safe Are Children With Covid-19 From Cardiac Risks? Pediatric Risk Assessment, insights from Echocardiography and Electrocardiography
99 [GO] 2021―Jan―12 The clinical impact of the COVID-19 pandemic on daily urological practice: First 3 month multicenter results from Istanbul
100 [GO] 2021―Jan―10 Evaluation of Systemic Involvement of Coronavirus Disease 2019 through Spleen; Size and Texture Analysis
101 [GO] 2020―Dec―22 Consensus Recommendations for Botulinum Toxin Injections in the Spasticity Management of Children with Cerebral Palsy During COVID-19 Outbreak
102 [GO] 2020―Dec―14 Factors affecting mortality in geriatric patients hospitalized with COVID-19
103 [GO] 2020―Dec―14 Influence of aluminum salts on COVID-19 infected patients Ali DEMİR, İbrahim ERAYMAN, Oğuz DOĞAN, Murat KEKİLLİ
104 [GO] 2020―Dec―14 The predictive and diagnostic accuracy of long Pentraxin-3 in COVID-19 Pneumonia
105 [GO] 2020―Dec―14 Evaluation of Initial Chest CT Findings of COVID-19 Pneumonia in 117 Deceased Patients: a Retrospective Study
106 [GO] 2020―Dec―11 A SENSITIVE INDICATOR FOR THE SEVERITY OF COVID-19: THIOL
107 [GO] 2020―Nov―27 Tocilizumab and COVID-19: A Meta-Analysis of 2120 Patients with Severe Disease and Implications for Clinical Trial Methodologies
108 [GO] 2020―Nov―25 Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey
109 [GO] 2020―Nov―16 THE IMPORTANCE OF QUALITY AND ACCREDITATION IN HEALTH CARE SERVICES IN THE PROCESS OF STRUGGLE AGAINST COVID-19
110 [GO] 2020―Nov―13 Clinical course of COVID-19 disease in immunosuppressed renal transplant patients
111 [GO] 2020―Nov―13 Characteristics and Outcomes of Critically Ill Patients with Covid-19 in Sakarya, Turkey: A Single Center Cohort Study
112 [GO] 2020―Oct―29 Pre-emptive Action Saves Lives in A Pandemic: Closing the Grand Bazaar Before The Fire Of COVID-19 Infection Starts
113 [GO] 2020―Oct―20 A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
114 [GO] 2020―Oct―06 Cerebral hemodynamic alterations in patients with Covid-19
115 [GO] 2020―Oct―06 COVID-19 transmission sources, management, and scientific research in Turkey
116 [GO] 2020―Oct―02 Do initial hematologic indices predict the severity of COVID-19 patients?
117 [GO] 2020―Sep―20 Efficacy of convalescent plasma according to blood groups in COVID-19 patients.
118 [GO] 2020―Sep―20 Characteristics and Mortality Determinants of COVID-19 Patients Undergoing Haemodialysis
119 [GO] 2020―Aug―25 The impact of the "low molecular weight heparin" administration on the clinical course of COVID-19 disease
120 [GO] 2020―Aug―11 COVID-19 related anxiety in people living with HIV: An online cross-sectional study
121 [GO] 2020―Aug―11 Melatonin, Aging and COVID-19: Could melatonin be beneficial for COVID-19 treatment in elderly?
122 [GO] 2020―Jul―28 Perspectives for the immune plasma treatment of COVID-19
123 [GO] 2020―Jul―28 Hepatitis A susceptibility parallels high COVID-19 mortality
124 [GO] 2020―Jul―28 Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU
125 [GO] 2020―Jul―19 COVID-19 experience of the major pandemic response center in the capital: Results of the pandemic's first month in Turkey
126 [GO] 2020―Jul―19 The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data
127 [GO] 2020―Jun―30 COVID-19 and dermatology
128 [GO] 2020―Jun―30 The factors predicting pneumonia in COVID-19 patients: preliminary results of a university hospital in Turkey
129 [GO] 2020―Jun―12 Projecting the Course of COVID-19 in Turkey: A Probabilistic Modeling Approach
130 [GO] 2020―Jun―09 COVID-19: Pathogenesis, genetic polymorphism, flinical features and laboratory findings
131 [GO] 2020―Jun―04 The effects of blood group types on the risk of COVID-19 infection and its clinical outcome
132 [GO] 2020―May―31 Letter to the Editor: Radiological approaches to COVID-19 pneumonia
133 [GO] 2020―May―31 Response to letter to the editor: radiological approaches to COVID-19 pneumonia
134 [GO] 2020―May―31 Characteristics of the initial patients hospitalized for COVID-19: a single-center report
135 [GO] 2020―May―18 Is there relationship between SARS-CoV 2 and the complement C3 and C4?
136 [GO] 2020―May―12 Chest CT features of the novel coronavirus disease (COVID-19)
137 [GO] 2020―Apr―30 The usual course of thorax CT findings of Covid-19 infection and when should control thorax CT scan?
138 [GO] 2020―Apr―30 Gynecological laparoscopic surgery in the shade of COVID-19 pandemic
139 [GO] 2020―Apr―18 Novel coronavirus disease (COVID-19) in children Hasan TEZER, Tuğba BEDİR DEMİRDAĞ
140 [GO] 2020―Apr―18 COVID-19 outbreak control, example of ministry of health of Turkey Yasemin DEMİRBİLEK, Gülen PEHLİVANTÜRK, Zeynep Özge ÖZGÜLER, Emine ALP MEŞE
141 [GO] 2020―Apr―18 Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic Hasan MANDAL
142 [GO] 2020―Apr―18 Global surveillance, travel, and trade during a pandemic Ceren ÇETİN, Ateş KARA
143 [GO] 2020―Apr―17 Epidemiology of COVID-19 Cemal BULUT, Yasuyuki KATO
144 [GO] 2020―Apr―17 Protective measures for COVID-19 for healthcare providers and laboratory personnel Canan AĞALAR, Derya ÖZTÜRK ENGİN
145 [GO] 2020―Apr―17 COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs Abdurrahman TUFAN, Aslıhan AVANOĞLU GÜLER, Marco MATUCCI-CERINIC
146 [GO] 2020―Apr―17 Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic Zeliha KOÇAK TUFAN, Bircan KAYAASLAN
147 [GO] 2020―Apr―17 Radiological approaches to COVID-19 pneumonia Şule AKÇAY, Tevfik ÖZLÜ, Aydın YILMAZ
148 [GO] 2020―Apr―17 Understanding dynamics of pandemics Levent AKIN, Mustafa Gökhan GÖZEL
149 [GO] 2020―Apr―15 Antiviral treatment of COVID-19
150 [GO] 2020―Apr―15 Emerging and reemerging respiratory viral infections up to Covid-19
151 [GO] 2020―Apr―15 Critically-ill COVID-19 patient
152 [GO] 2020―Apr―15 COVID-19: Prevention and control measures in community
153 [GO] 2020―Apr―15 Coronaviruses and SARS-CoV-2
154 [GO] 2020―Apr―14 The early impact of the Covid-19 pandemic on the global and Turkish economy
155 [GO] 2020―Apr―14 SARS-CoV-2 epidemiology and control, different scenarios for Turkey
 [1] 

155 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec